Advertisement

Advertisement

Optimizing the Care Continuum for EGFR-Mutant NSCLC

Case 3: Perioperative Management of Resectable EGFR-Mutant NSCLC

lung cancer

Case 2: Acquired Resistance After First-Line Osimertinib-Based Therapy in EGFR L858R–Mutant NSCLC

This is Part 2 of Optimizing the Care Continuum for EGFR-Mutant NSCLC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable.    In this video, Drs. Suresh R...

lung cancer

Case 1: First-Line Therapy for EGFR-Mutant Metastatic NSCLC

This is Part 1 of Optimizing the Care Continuum for EGFR-Mutant NSCLC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable.   In this video, Drs. Suresh Ra...

Advertisement

Advertisement




Advertisement